Table 1.

Study subject characteristics

Abbreviations: cART = combined antiretroviral therapy; dIRIS = delayed IRIS; IRIS = immune reconstitution inflammatory syndrome; NA = not applicable; PML = progressive multifocal leukoencephalopathy; PML-P = PML progressors; PML-S = PML-survivors; sIRIS = simultaneous IRIS; U = undetectable; VL = viral load.

^a Chronic lymphocytic leukemia, non-Hodgkin lymphoma, acute myeloid leukemia, abdominal B-cell lymphoma, natural killer cell leukemia.

^b Brainstem glioma, non-small cell lung cancer.

^c Idiopathic CD4+ or CD8+ T-cell lymphocytopenia, Waldenstrom macroglobulinemia, common variable immunodeficiency, Good syndrome, lymphomatosis granulomatosis.

^d Multiple sclerosis treated with natalizumab, lupus erythematosus, dermatomyositis, rheumatoid arthritis.

^e Alcoholic cirrhosis.